Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 May 13:15:167.
doi: 10.1186/1745-6215-15-167.

The challenge of recruiting patients into a placebo-controlled surgical trial

Affiliations
Randomized Controlled Trial

The challenge of recruiting patients into a placebo-controlled surgical trial

Kristoffer B Hare et al. Trials. .

Abstract

Background: Randomized placebo-controlled trials represent the gold standard in evaluating healthcare interventions but are rarely performed within orthopedics. Ethical concerns or well-known challenges in recruiting patients for surgical trials in general have been expressed and adding a placebo component only adds to this complexity. The purpose of this study was to report the challenges of recruiting patients into an orthopedic placebo-controlled surgical trial, to determine the number of patients needed to be screened and allocated in order to include one participant into the trial, and to identify reasons associated with participation in a placebo-controlled randomized surgical trial.

Methods: Data were extracted from an ongoing placebo-controlled randomized controlled trial (RCT) on meniscectomy versus placebo surgery. We calculated the number of patients needed to be screened in order to include the required number of participants into the RCT. Participating patients were asked about their rationale for joining the study and which type of information was most useful for deciding upon participation.

Results: A total of 476 patients entered the screening group, of which 190 patients fulfilled the inclusion and exclusion criteria. 102 patients declined to participate in the study due to various reasons and 46 were later excluded (no meniscus lesion on the magnetic resonance imaging scan or withdrawn consent). A total of 40 patients were finally included in the RCT. To include one patient into the RCT, 11.9 individuals needed to be screened. A total of 69% of participating patients considered the oral information to be the most important and the most common reason for participating was the contribution to research (90%).

Conclusions: Patients are willing to participate in an orthopedic placebo-controlled surgical trial. Oral information given by the surgeon to the patient and the contribution to research are important aspects to enhance patient recruitment.

Trial registration: ClinicalTrials.gov NCT01264991, registered 21 December 2010.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of the recruitment process in this RCT. †4 patients underwent an MRI which was negative before being informed of the study. BMI, Body Mass Index; RCT, randomized controlled trial.

References

    1. Armitage P. The role of randomization in clinical trials. Stat Med. 1982;1:345–352. doi: 10.1002/sim.4780010412. - DOI - PubMed
    1. London AJ, Kadane JB. Placebo that harms: sham surgery controls in clinical trials. Stat Methods Med Res. 2002;11:413–427. doi: 10.1191/0962280202sm300ra. - DOI - PubMed
    1. Macklin R. The ethical problems of sham surgery in clinical trials. N Engl J Med. 1999;341:992–996. doi: 10.1056/NEJM199909233411312. - DOI - PubMed
    1. Ergina PL, Cook JA, Blazeby JM, Boutron I, Clavien P-A, Reeves BC, Seiler CM. Challenges in evaluating surgical innovation. Lancet. 2009;374:1097–1104. doi: 10.1016/S0140-6736(09)61086-2. - DOI - PMC - PubMed
    1. McLeod RS. Issues in surgical randomized controlled trials. World J Surg. 1999;23:1210–1214. doi: 10.1007/s002689900649. - DOI - PubMed

Publication types

Associated data